<?xml version="1.0" encoding="UTF-8"?>
<doc:document xmlns:doc="http://www.elsevier.com/xml/document/schema"
              xmlns:dp="http://www.elsevier.com/xml/common/doc-properties/schema"
              xmlns:cps="http://www.elsevier.com/xml/common/consyn-properties/schema"
              xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
              xmlns:dct="http://purl.org/dc/terms/"
              xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/"
              xmlns:oa="http://vtw.elsevier.com/data/ns/properties/OpenAccess-1/"
              xmlns:bam="http://vtw.elsevier.com/data/voc/ns/bam-vtw-1/"
              xmlns:cp="http://vtw.elsevier.com/data/ns/properties/Copyright-1/"
              xmlns:cja="http://www.elsevier.com/xml/cja/schema"
              xmlns:ja="http://www.elsevier.com/xml/ja/schema"
              xmlns:bk="http://www.elsevier.com/xml/bk/schema"
              xmlns:ce="http://www.elsevier.com/xml/common/schema"
              xmlns:mml="http://www.w3.org/1998/Math/MathML"
              xmlns:cals="http://www.elsevier.com/xml/common/cals/schema"
              xmlns:tb="http://www.elsevier.com/xml/common/table/schema"
              xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/schema"
              xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/schema"
              xmlns:xlink="http://www.w3.org/1999/xlink">
   <rdf:RDF>
      <rdf:Description rdf:about="http://dx.doi.org/10.1016/j.phyplu.2022.100229">
         <dct:format>application/xml</dct:format>
         <dct:title>Anti-oxidant profile of Divya-Peedantak-Vati abates paclitaxel-induced hyperalgesia and allodynia in CD-1 mice model of neuropathic pain</dct:title>
         <dct:creator>Acharya Balkrishna</dct:creator>
         <dct:creator>Shadrak Karumuri</dct:creator>
         <dct:creator>Sachin S Sakat</dct:creator>
         <dct:creator>Swati Haldar</dct:creator>
         <dct:creator>Anurag Varshney</dct:creator>
         <dct:subject>
            <rdf:Bag>
               <rdf:li>Paclitaxel</rdf:li>
               <rdf:li>Divya-Peedantak-Vati</rdf:li>
               <rdf:li>Ayurvedic medicine</rdf:li>
               <rdf:li>CIPN model</rdf:li>
               <rdf:li>Anti-oxidant</rdf:li>
               <rdf:li>Anti-inflammatory</rdf:li>
            </rdf:Bag>
         </dct:subject>
         <dct:description>Phytomedicine Plus 2 (2022). doi:10.1016/j.phyplu.2022.100229</dct:description>
         <prism:aggregationType>journal</prism:aggregationType>
         <prism:publicationName>Phytomedicine Plus</prism:publicationName>
         <prism:copyright>© 2022 The Author(s). Published by Elsevier B.V.</prism:copyright>
         <dct:publisher>Elsevier B.V.</dct:publisher>
         <prism:issn>2667-0313</prism:issn>
         <prism:volume>2</prism:volume>
         <prism:number>2</prism:number>
         <prism:coverDisplayDate>May 2022</prism:coverDisplayDate>
         <prism:doi>10.1016/j.phyplu.2022.100229</prism:doi>
         <prism:url>http://dx.doi.org/10.1016/j.phyplu.2022.100229</prism:url>
         <dct:identifier>doi:10.1016/j.phyplu.2022.100229</dct:identifier>
         <bam:articleNumber>100229</bam:articleNumber>
         <oa:openAccessInformation>
            <oa:openAccessStatus xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://vtw.elsevier.com/data/voc/oa/OpenAccessStatus#Full</oa:openAccessStatus>
            <oa:openAccessEffective xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">2022-01-26T05:40:08Z</oa:openAccessEffective>
            <oa:sponsor xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
               <oa:sponsorType>http://vtw.elsevier.com/data/voc/oa/SponsorType#Author</oa:sponsorType>
            </oa:sponsor>
            <oa:userLicense xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://creativecommons.org/licenses/by-nc-nd/4.0/</oa:userLicense>
         </oa:openAccessInformation>
         <cp:licenseLine xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">This is an open access article under the CC BY-NC-ND license.</cp:licenseLine>
      </rdf:Description>
   </rdf:RDF>
   <dp:document-properties>
      <dp:aggregation-type>Journals</dp:aggregation-type>
      <dp:version-number>S250.1</dp:version-number>
   </dp:document-properties>
   <ja:article docsubtype="fla" version="5.6" xml:lang="en">
      <ja:item-info>
         <ja:jid>PHYPLU</ja:jid>
         <ja:aid>100229</ja:aid>
         <ce:article-number>100229</ce:article-number>
         <ce:pii>S2667-0313(22)00015-X</ce:pii>
         <ce:doi>10.1016/j.phyplu.2022.100229</ce:doi>
         <ce:copyright type="other" year="2022">The Author(s)</ce:copyright>
      </ja:item-info>
      <ja:head>
         <ce:title id="tte0002">Anti-oxidant profile of Divya-Peedantak-Vati abates paclitaxel-induced hyperalgesia and allodynia in CD-1 mice model of neuropathic pain</ce:title>
         <ce:author-group id="aut0001">
            <ce:author id="au0001"
                       author-id="S266703132200015X-c8b8a0106f0e4b6d71e4c090ff4b37d9">
               <ce:given-name>Acharya</ce:given-name>
               <ce:surname>Balkrishna</ce:surname>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/conceptualization">Conceptualization</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/resources">Resources</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/project-administration">Project administration</ce:contributor-role>
               <ce:cross-ref refid="aff0001">
                  <ce:sup loc="post">a</ce:sup>
               </ce:cross-ref>
               <ce:cross-ref refid="aff0002">
                  <ce:sup loc="post">b</ce:sup>
               </ce:cross-ref>
            </ce:author>
            <ce:author id="au0002"
                       author-id="S266703132200015X-9df6b09c6d8323d6218790b642527938">
               <ce:given-name>Shadrak</ce:given-name>
               <ce:surname>Karumuri</ce:surname>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/investigation">Investigation</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/methodology">Methodology</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/visualization">Visualization</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/data-curation">Data curation</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/software">Software</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/formal-analysis">Formal analysis</ce:contributor-role>
               <ce:cross-ref refid="aff0001">
                  <ce:sup loc="post">a</ce:sup>
               </ce:cross-ref>
            </ce:author>
            <ce:author id="au0003"
                       author-id="S266703132200015X-ca7c840682037c912da663494e450e0b">
               <ce:given-name>Sachin S</ce:given-name>
               <ce:surname>Sakat</ce:surname>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/investigation">Investigation</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/validation">Validation</ce:contributor-role>
               <ce:cross-ref refid="aff0001">
                  <ce:sup loc="post">a</ce:sup>
               </ce:cross-ref>
            </ce:author>
            <ce:author id="au0004"
                       author-id="S266703132200015X-d8f7f9e7bfce9f07c2a6d875835928b2">
               <ce:given-name>Swati</ce:given-name>
               <ce:surname>Haldar</ce:surname>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-original-draft">Writing – original draft</ce:contributor-role>
               <ce:cross-ref refid="aff0001">
                  <ce:sup loc="post">a</ce:sup>
               </ce:cross-ref>
            </ce:author>
            <ce:author id="au0005"
                       author-id="S266703132200015X-905e307a68e5e88d1ad9685da4e6397f">
               <ce:given-name>Anurag</ce:given-name>
               <ce:surname>Varshney</ce:surname>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/conceptualization">Conceptualization</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/supervision">Supervision</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-review-editing">Writing – review &amp; editing</ce:contributor-role>
               <ce:cross-ref refid="aff0001">
                  <ce:sup loc="post">a</ce:sup>
               </ce:cross-ref>
               <ce:cross-ref refid="aff0002">
                  <ce:sup loc="post">b</ce:sup>
               </ce:cross-ref>
               <ce:cross-ref refid="aff0003">
                  <ce:sup loc="post">c</ce:sup>
               </ce:cross-ref>
               <ce:cross-ref refid="cor0001">
                  <ce:sup loc="post">⁎</ce:sup>
               </ce:cross-ref>
               <ce:e-address id="ead0001" type="email" xlink:href="mailto:anurag@prft.co.in">anurag@prft.co.in</ce:e-address>
            </ce:author>
            <ce:affiliation id="aff0001"
                            affiliation-id="S266703132200015X-184f83d5906d22683c41548057d4064e">
               <ce:label>a</ce:label>
               <ce:textfn id="cetextfn0001">Drug Discovery and Development Division, Patanjali Research Institute, Haridwar, Uttarakhand 249405, India</ce:textfn>
               <sa:affiliation>
                  <sa:organization>Drug Discovery and Development Division</sa:organization>
                  <sa:organization>Patanjali Research Institute</sa:organization>
                  <sa:city>Haridwar</sa:city>
                  <sa:state>Uttarakhand</sa:state>
                  <sa:postal-code>249405</sa:postal-code>
                  <sa:country>India</sa:country>
               </sa:affiliation>
               <ce:source-text id="staff0001">aDrug Discovery and Development Division, Patanjali Research Institute, Haridwar, Uttarakhand 249405, India</ce:source-text>
            </ce:affiliation>
            <ce:affiliation id="aff0002"
                            affiliation-id="S266703132200015X-f2ce2e9ba8f91a89e4d15342059bbe35">
               <ce:label>b</ce:label>
               <ce:textfn id="cetextfn0002">Department of Allied and Applied Sciences, University of Patanjali, Haridwar, Uttarakhand, India</ce:textfn>
               <sa:affiliation>
                  <sa:organization>Department of Allied and Applied Sciences</sa:organization>
                  <sa:organization>University of Patanjali</sa:organization>
                  <sa:city>Haridwar</sa:city>
                  <sa:state>Uttarakhand</sa:state>
                  <sa:country>India</sa:country>
               </sa:affiliation>
               <ce:source-text id="staff0002">bDepartment of Allied and Applied Sciences, University of Patanjali, Haridwar, Uttarakhand, India</ce:source-text>
            </ce:affiliation>
            <ce:affiliation id="aff0003"
                            affiliation-id="S266703132200015X-93f96d2e63d08640d0245f5b04833cc0">
               <ce:label>c</ce:label>
               <ce:textfn id="cetextfn0003">Special Centre for Systems Medicine, Jawaharlal Nehru University, New Delhi, India</ce:textfn>
               <sa:affiliation>
                  <sa:organization>Special Centre for Systems Medicine</sa:organization>
                  <sa:organization>Jawaharlal Nehru University</sa:organization>
                  <sa:city>New Delhi</sa:city>
                  <sa:country>India</sa:country>
               </sa:affiliation>
               <ce:source-text id="staff0003">cSpecial Centre for Systems Medicine, Jawaharlal Nehru University, New Delhi, India</ce:source-text>
            </ce:affiliation>
            <ce:correspondence id="cor0001">
               <ce:label>⁎</ce:label>
               <ce:text id="cetext0001">Corresponding author at: Drug Discovery and Development Division, Patanjali Research Institute, Haridwar, Uttarakhand 249405, India.</ce:text>
               <sa:affiliation>
                  <sa:organization>Drug Discovery and Development Division</sa:organization>
                  <sa:organization>Patanjali Research Institute</sa:organization>
                  <sa:city>Haridwar</sa:city>
                  <sa:state>Uttarakhand</sa:state>
                  <sa:postal-code>249405</sa:postal-code>
                  <sa:country>India</sa:country>
               </sa:affiliation>
            </ce:correspondence>
         </ce:author-group>
         <ce:date-received day="26" month="11" year="2021"/>
         <ce:date-revised day="17" month="1" year="2022"/>
         <ce:date-accepted day="25" month="1" year="2022"/>
         <ce:abstract id="abs0001" view="all" class="author">
            <ce:section-title id="cesectitle0001">Abstract</ce:section-title>
            <ce:abstract-sec id="abss0001" role="background" view="all">
               <ce:section-title id="cesectitle0002">Background</ce:section-title>
               <ce:simple-para id="spara007" view="all">Paclitaxel (PTX) is a known chemotherapeutic agent, used to treat different types of cancers. However, it leads to neuropathic pain in a sizeable proportion of the patients. Currently, analgesics, opioids, tricyclic antidepressants and anticonvulsants are prescribed for PTX-mediated chemotherapy-induced peripheral neuropathy (CIPN). However, these treatments have acute side-effects, creating a need for safer alternative treatment option.</ce:simple-para>
            </ce:abstract-sec>
            <ce:abstract-sec id="abss0002" role="materials-methods" view="all">
               <ce:section-title id="cesectitle0003">Method</ce:section-title>
               <ce:simple-para id="spara008" view="all">PTX-mediated CIPN has nociceptive outcomes, like, allodynia and hyperalgesia with an underlying inflammatory and oxidative causes. The herbo-mineral medicine, Divya-Peedantak-Vati (DPV) is known for its effectivity against joint pain and inflammatory disorders in Ayurveda, a traditional Indian system of medicine. Therefore, anti-neuropathic potential of DPV was assessed in PTX-induced neuropathic CD-1 mice, with allodynia and hyperalgesia, as the clinically relevant endpoints. DPV was investigated for its nociception-modulatory and anti-inflammatory effects under <ce:italic>in vivo</ce:italic> and <ce:italic>in vitro</ce:italic> conditions.</ce:simple-para>
            </ce:abstract-sec>
            <ce:abstract-sec id="abss0003" role="results" view="all">
               <ce:section-title id="cesectitle0004">Results</ce:section-title>
               <ce:simple-para id="spara009" view="all">DPV treatment exhibited notable anti-allodynic and anti-hyperalgesic effects in a dose dependent manner, and displayed prominent anti-oxidant effects in the sciatic nerve of the study animals. It also moderated, in a dose dependent manner, the levels of cytokine, interleukin-1beta (IL-1β) and tumor necrosis factor alpha (TNF-α) induced nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling.</ce:simple-para>
            </ce:abstract-sec>
            <ce:abstract-sec id="abss0004" role="conclusion" view="all">
               <ce:section-title id="cesectitle0005">Conclusions</ce:section-title>
               <ce:simple-para id="spara010" view="all">The novelty of this study lies in the demonstration of the anti-neuropathic potential and elucidation of anti-neuropathic mode-of-action of an herbal medicine. Taken together, this study showed that DPV could well be an effective alternative healing option for PTX-mediated CIPN.</ce:simple-para>
            </ce:abstract-sec>
         </ce:abstract>
         <ce:keywords id="keys0001" view="all" class="keyword">
            <ce:section-title id="cesectitle0006">Keywords</ce:section-title>
            <ce:keyword id="key0001">
               <ce:text id="cetext0002">Paclitaxel</ce:text>
            </ce:keyword>
            <ce:keyword id="key0002">
               <ce:text id="cetext0003">Divya-Peedantak-Vati</ce:text>
            </ce:keyword>
            <ce:keyword id="key0003">
               <ce:text id="cetext0004">Ayurvedic medicine</ce:text>
            </ce:keyword>
            <ce:keyword id="key0004">
               <ce:text id="cetext0005">CIPN model</ce:text>
            </ce:keyword>
            <ce:keyword id="key0005">
               <ce:text id="cetext0006">Anti-oxidant</ce:text>
            </ce:keyword>
            <ce:keyword id="key0006">
               <ce:text id="cetext0007">Anti-inflammatory</ce:text>
            </ce:keyword>
         </ce:keywords>
      </ja:head>
   </ja:article>
</doc:document>
